Birznieks Gunther 4
4 · Vanda Pharmaceuticals Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Birznieks Gunther
SVP, Business Development
Transactions
- Tax Payment
Common Stock
2025-03-01$4.76/sh−26,941$128,239→ 411,628 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.